Obinutuzumab is a targeted therapy drug used to treat Chronic Lymphocytic Leukemia and Follicular lymphoma.
-
-
“Nivolumab is a targeted therapy drug used to treat Melanoma, Metastatic Non-small cell lung cancer, Metastatic small cell lung cancer, Advanced kidney cancer, Liver cancer, Hodgkin’s lymphoma, Metastatic squamous cell carcinoma of the head and neck, Advanced or metastatic urothelial carcinoma, and Colorectal cancer.”
-
Nilotinib is a targeted therapy drug used to treat Ph+ chronic myeloid leukemia.
-
Lapatinib is a targeted therapy drug used to treat HER-2 positive Metastatic breast cancer.
-
Imatinib mesylate is a targeted therapy drug used to treat Chronic myeloid leukemia, Acute lymphoblastic leukemia, Gastrointestinal stromal tumours, Hypereosinophilic syndrome, Dermatofibrosarcoma protuberans, Systemic mastocytosis, Myelodysplastic or myeloproliferative diseases.
-
Ibrutinib is a targeted therapy drug used to treat mantle cell lymphoma, chronic lymphocytic leukemia, marginal zone lymphoma, waldenstrom’s macroglobulinemia, chronic graft vs host disease, and small lymphocytic lymphoma.
-
“Ibritumomab tiuxetan is a targeted therapy drug used to treat Non-Hodgkin’s lymphoma and Follicular B-cell non-Hodgkin’s lymphoma.”
-
Gefitinib is a targeted therapy drug used to treat metastatic non-small cell lung cancer that has shown EGFR mutations.
-
Everolimus is a targeted therapy drug used to treat Breast cancer, Kidney cancer, Pancreatic cancer, stomach cancer, Lung cancer, Subependymal giant cell astrocytoma (a type of brain tumour), and Prevents transplant rejection in patients who have received kidney transplantation.
-
Erlotinib is a targeted therapy drug used to treat metastatic non-small cell lung cancer, metastatic Pancreatic cancer, and advanced kidney cancer.
